{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:10:26Z","timestamp":1767978626478,"version":"3.49.0"},"reference-count":14,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"vor","delay-in-days":11074,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1982,4]]},"abstract":"<jats:p>1 Twenty\u2010seven patients with moderate to severe chronic pain of malignant origin received buprenorphine (0.3 mg) and morphine (10 mg) intramuscularly in a double\u2010blind, single dose within patient study. 2 Efficacy analysis demonstrated no significant differences in the peak analgesic effects or in the time to reach these effects. However, buprenorphine had a significantly longer duration of action than morphine. 3 Sedation was the most frequent unwanted effect with a similar incidence following each treatment. Buprenorphine was associated with a significantly higher incidence, greater severity, earlier onset, and longer duration of dizziness, nausea and vomiting than morphine. 4 Following both treatments there were small but significant decreases in pulse rate, blood pressure, and respiratory rate.<\/jats:p>","DOI":"10.1111\/j.1365-2125.1982.tb01409.x","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T19:55:01Z","timestamp":1450295701000},"page":"487-492","source":"Crossref","is-referenced-by-count":20,"title":["A comparative study of intramuscular buprenorphine and morphine in the treatment of chronic pain of malignant origin."],"prefix":"10.1111","volume":"13","author":[{"given":"M","family":"Kjaer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"187","article-title":"Clinical use of buprenorphine in chronic administrationlg","volume":"27","author":"ADRIAESEN H.","year":"1976","journal-title":"Acta anaesh belg."},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/49.3.251"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6183.163"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6185.300"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/49.9.913"},{"key":"e_1_2_1_7_1","first-page":"417","article-title":"Pain relief in the post\u2010operative period: A comparative trial of morphine and a new analgesic buprenorphine","volume":"5","author":"HOVELL B.C.","year":"1977","journal-title":"J. Int. med. Res."},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770280111012"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/50.6.599"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/50.6.605"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1981.tb01128.x"},{"key":"e_1_2_1_12_1","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1742-1241.1979.tb07675.x","article-title":"Intramuscular buprenorphine\u2014Clinical experience in its use for relieving pain due to malignant disease","volume":"33","author":"OSTROWSKI M.J.","year":"1978","journal-title":"Br. J. clin. Pract."},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1979.tb04706.x"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1980.tb01818.x"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1980.tb01584.x"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.1982.tb01409.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.1982.tb01409.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.1982.tb01409.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T10:16:11Z","timestamp":1699697771000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.1982.tb01409.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1982,4]]}},"alternative-id":["10.1111\/j.1365-2125.1982.tb01409.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.1982.tb01409.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,4]]}}}